These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 28888050)
1. Significance of perivascular tumour cells defined by CD109 expression in progression of glioma. Shiraki Y; Mii S; Enomoto A; Momota H; Han YP; Kato T; Ushida K; Kato A; Asai N; Murakumo Y; Aoki K; Suzuki H; Ohka F; Wakabayashi T; Todo T; Ogawa S; Natsume A; Takahashi M J Pathol; 2017 Dec; 243(4):468-480. PubMed ID: 28888050 [TBL] [Abstract][Full Text] [Related]
2. CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity. Filppu P; Tanjore Ramanathan J; Granberg KJ; Gucciardo E; Haapasalo H; Lehti K; Nykter M; Le Joncour V; Laakkonen P JCI Insight; 2021 May; 6(9):. PubMed ID: 33986188 [TBL] [Abstract][Full Text] [Related]
3. Revealing the glioma cancer stem cell interactome, one niche at a time. Silver DJ; Lathia JD J Pathol; 2018 Mar; 244(3):260-264. PubMed ID: 29282720 [TBL] [Abstract][Full Text] [Related]
4. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells. Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773 [TBL] [Abstract][Full Text] [Related]
5. CXCR4-positive subset of glioma is enriched for cancer stem cells. Zheng X; Xie Q; Li S; Zhang W Oncol Res; 2011; 19(12):555-61. PubMed ID: 22812188 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a side population of astrocytoma cells in response to temozolomide. Chua C; Zaiden N; Chong KH; See SJ; Wong MC; Ang BT; Tang C J Neurosurg; 2008 Nov; 109(5):856-66. PubMed ID: 18976075 [TBL] [Abstract][Full Text] [Related]
7. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells. Shen D; Guo CC; Wang J; Qiu ZK; Sai K; Yang QY; Chen YS; Chen FR; Wang J; Panasci L; Chen ZP Oncol Rep; 2015 Nov; 34(5):2715-21. PubMed ID: 26329778 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. Ulasov IV; Nandi S; Dey M; Sonabend AM; Lesniak MS Mol Med; 2011; 17(1-2):103-12. PubMed ID: 20957337 [TBL] [Abstract][Full Text] [Related]
9. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro. Zhou S; da Silva SD; Siegel PM; Philip A Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056 [TBL] [Abstract][Full Text] [Related]
10. Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV. Niibori-Nambu A; Midorikawa U; Mizuguchi S; Hide T; Nagai M; Komohara Y; Nagayama M; Hirayama M; Kobayashi D; Tsubota N; Takezaki T; Makino K; Nakamura H; Takeya M; Kuratsu J; Araki N PLoS One; 2013; 8(5):e59558. PubMed ID: 23704872 [TBL] [Abstract][Full Text] [Related]
11. Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence. Guichet PO; Masliantsev K; Tachon G; Petropoulos C; Godet J; Larrieu D; Milin S; Wager M; Karayan-Tapon L J Pathol; 2018 Oct; 246(2):205-216. PubMed ID: 30009411 [TBL] [Abstract][Full Text] [Related]
12. Stem cell markers in glioma progression and recurrence. Hattermann K; Flüh C; Engel D; Mehdorn HM; Synowitz M; Mentlein R; Held-Feindt J Int J Oncol; 2016 Nov; 49(5):1899-1910. PubMed ID: 27600094 [TBL] [Abstract][Full Text] [Related]
13. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis. Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232 [TBL] [Abstract][Full Text] [Related]
14. Temozolomide resistant human brain tumor stem cells are susceptible to recombinant vesicular stomatitis virus and double-deleted Vaccinia virus in vitro. Jiang B; Lun X; Hao X; Wang Y; Yin X; Huang D; He W; Wang Z Biomed Pharmacother; 2017 Nov; 95():1201-1208. PubMed ID: 28931212 [TBL] [Abstract][Full Text] [Related]
15. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling. Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133 [TBL] [Abstract][Full Text] [Related]
16. Eukaryotic initiation factor 5B (eIF5B) regulates temozolomide-mediated apoptosis in brain tumour stem cells (BTSCs). Ross JA; Ahn BY; King J; Bressler KR; Senger DL; Thakor N Biochem Cell Biol; 2020 Dec; 98(6):647-652. PubMed ID: 31671279 [TBL] [Abstract][Full Text] [Related]
17. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243 [TBL] [Abstract][Full Text] [Related]
19. 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility. Dai X; Ma C; Lan Q; Xu T Biofabrication; 2016 Oct; 8(4):045005. PubMed ID: 27725343 [TBL] [Abstract][Full Text] [Related]
20. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis. Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]